Hospital-acquired conditions declined by 13 percent between 2014 and 2017, preventing an estimated 20,500 deaths and $7.7 billion in health care costs, according to preliminary data from the Agency for Healthcare Research and Quality. HACs decreased by an estimated 910,000 over the period, including a 37 percent decline in C. difficile infections and 28 percent decline in adverse drug events, showing that patient safety initiatives such as the Hospital Improvement Innovation Networks are working to make health care safer, the agency said. AHA’s Health Research & Educational Trust leads the nation’s largest HIIN. 
 

Headline
The Centers for Disease Control and Prevention has reported 843 cases of cyclosporiasis across 31 states, with 86 people hospitalized. State health departments…
Headline
The Food and Drug Administration has issued an early alert for specific lots of BD ChloraPrep Applicators by Medline because of a potential breach of sterility…
Headline
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
Angela Hewlett, M.D., professor of infectious diseases at the University of Nebraska Medical Center and medical director of the Nebraska Biocontainment Unit,…
Headline
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…
Headline
The Administration for Strategic Preparedness and Response June 16 announced the launch of the Digital Stockpile and Manufacturing Response Network Challenge,…